Chinese investor spends 1.3 billion USD on global healthcare deal
Earlier this year, the pharmaceutical arm of Fosun International, a Chinese company with a market cap of over 13 billion USD, announced a1.3 billion USD buyout of India based Gland Pharma. Chinese companies are increasingly making healthcare deals abroad in order to become relevant and active players in the global healthcare market. The domestic market…